Close Menu

NEW YORK – Accelerate Diagnostics today announced that a version of its PhenoTest BC kit including additional antimicrobial susceptibility testing has received CE-IVD marking and is now available to hospitals and health systems in regions that recognize the CE mark.

The expanded kit includes phenotypic antimicrobial susceptibility test results for the antimicrobials ceftazidime-avibactam and ceftolozane-tazobactam for Enterobacteriaceae and P. aeruginosa bacteria, and trimethoprim-sulfamethoxazole for A. baumannii bacteria.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.